Generated by AI
The Oncology Institute, Inc. is a value-based community oncology group providing comprehensive cancer care treatment services across multiple settings. Operating through three primary segments—Dispensary, Patient Care, and Clinical Trials and Other—the company delivers specialized oncology services including infusion centers, in-house pharmaceutical dispensary, outpatient blood transfusions, outpatient stem cell transplants, financial counseling, clinical trials, comprehensive laboratory testing, and end-of-life counseling. With over 100 employed clinicians and more than 800 team members operating across numerous clinic locations, The Oncology Institute serves a large patient population with evidence-based, high-quality cancer care. Founded in 2007 and headquartered in Cerritos, California, the company focuses on advancing oncology through value-based care models designed to improve patient outcomes while optimizing healthcare delivery in community settings rather than traditional hospital environments.
Website18000 Studebaker Road
Cerritos, CA, 90703
United States
The latest articles about TOI.
Oncology Institute (NASDAQ:TOI) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Tipranks Press Release.
Summary of Jul 9's posts. Generated by AI.
Summary of Mar 13's posts. Generated by AI.
Summary of Jul 9's posts. Generated by AI.
Investors talking about TOI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.